Disc Medicine Statistics

Total Valuation

Disc Medicine has a market cap or net worth of $1.35 billion. The enterprise value is $1.01 billion.

Market Cap	1.35B
Enterprise Value	1.01B

Important Dates

The next estimated earnings date is Friday, August 9, 2024, before market open.

Earnings Date	Aug 9, 2024
Ex-Dividend Date	n/a

Share Statistics

Disc Medicine has 29.67 million shares outstanding. The number of shares has increased by 30.89% in one year.

Shares Outstanding	29.67M
Shares Change (YoY)	+30.89%
Shares Change (QoQ)	+1.48%
Owned by Insiders (%)	12.54%
Owned by Institutions (%)	84.35%
Float	14.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.98
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 23.70, with a Debt / Equity ratio of 0.01.

Current Ratio	23.70
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -22.80% and return on invested capital (ROIC) is -28.66%.

Return on Equity (ROE)	-22.80%
Return on Assets (ROA)	-21.70%
Return on Capital (ROIC)	-28.66%
Revenue Per Employee	n/a
Profits Per Employee	-$1.09M
Employee Count	74
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Disc Medicine has paid $81,000 in taxes.

Income Tax	81,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.34% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-2.34%
50-Day Moving Average	39.73
200-Day Moving Average	49.63
Relative Strength Index (RSI)	53.13
Average Volume (20 Days)	421,201

Short Selling Information

The latest short interest is 1.58 million, so 5.31% of the outstanding shares have been sold short.

Short Interest	1.58M
Short Previous Month	2.00M
Short % of Shares Out	5.31%
Short % of Float	10.90%
Short Ratio (days to cover)	3.13

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-97.46M
Pretax Income	-80.52M
Net Income	-80.60M
EBITDA	-80.07M
EBIT	-80.52M
Earnings Per Share (EPS)	-$3.38

Full Income Statement

Balance Sheet

The company has $342.62 million in cash and $2.03 million in debt, giving a net cash position of $340.59 million or $11.48 per share.

Cash & Cash Equivalents	342.62M
Total Debt	2.03M
Net Cash	340.59M
Net Cash Per Share	$11.48
Equity (Book Value)	338.07M
Book Value Per Share	11.40
Working Capital	337.10M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$71.60 million and capital expenditures -$127,000, giving a free cash flow of -$71.72 million.

Operating Cash Flow	-71.60M
Capital Expenditures	-127,000
Free Cash Flow	-71.72M
FCF Per Share	-$2.89

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Disc Medicine does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.89%
Shareholder Yield	-30.89%
Earnings Yield	-5.98%
FCF Yield	-5.33%

Dividend Details

Analyst Forecast

The average price target for Disc Medicine is $63.50, which is 39.87% higher than the current price. The consensus rating is "Buy".

Price Target	$63.50
Price Target Difference	39.87%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	0.98%

Stock Forecasts

Stock Splits

The last stock split was on December 30, 2022. It was a reverse split with a ratio of 1:30.

Last Split Date	Dec 30, 2022
Split Type	Reverse
Split Ratio	1:30

Scores

Altman Z-Score	n/a
Piotroski F-Score	1